Case Studies & Testimonials

Read some testimonials left by patients and case studies of our previous trials.

You can plan a clinical trial meticulously but when you start a First-in-Human study prepare to be flexible!

Richmond Pharmacology has extensive experience of conducting First-in-Human clinical trials, including studies involving biologics, and we have a very experienced team on hand to help you. You can be sure we will rise to the occasion.

View Case Study

Data Management Case Study - April 09

Richmond Pharmacology has extensive experience in the conduct of intensive thorough QTc studies. We are proud to offer a dedicated, highly skilled team within an efficient and safe hospital environment, using state of the art technology.

View Case Study

Data Management Case Study - March 09

Timelines, Tight Timelines, And Even Tighter Timelines In A Phase I Environment.

View Case Study

The Richmond Pharmacology Japanese Team commits to a challenging study...and they deliver.

Richmond Pharmacology has extensive experience in the conduct of intensive thorough QTc studies. We are proud to offer a dedicated, highly skilled team within an efficient and safe hospital environment, using state of the art technology.

View Case Study

65 Subjects Vaccinated in 1 day

Recruitment can sometimes be a challenge, however the tighter the timelines and the larger the group required, the more Richmond Pharmacology rises to the challenge.

View Case Study

“I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.”

- Anonymous

“Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.”

- Anonymous

“Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.”

- Anonymous

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Making gains in drug development

September 2, 2021
Keith Berelowitz outlines the innovations in the design and delivery of clinical trials
Read more

Inclisirin hailed as a 'gamechanger' gains approval for NHS patients

September 2, 2021
This novel therapeutic drug has potential to impact millions at risk of heart attack and stroke.
Read more

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more